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iLeft-sided  portal  hypertension  (LSPH),  also  known  as
segmental,  regional,  localized,  compartmental,  lineal,
splenoportal,  or  sinistral  hypertension  is  a  rare,  but  life
threatening  cause  of  upper  gastrointestinal  bleeding.  It  usu-
ally  occurs  as  a  result  of  isolated  obstruction  of  the  splenic
vein.  The  incidence  of  LSPH  has  increased  over  the  past
three  decades  due  to  increased  awareness  of  the  entity  and
advances  in  diagnostic  approaches.  Since  most  patients  are
asymptomatic  and  experience  no  complications,  its  exact
incidence  is  unknown.  However,  it  accounts  for  less  than  5%
of  all  patients  with  portal  hypertension.1 To  date,  less  than
500  cases  of  LSPH  have  been  reported  in  all.  Most  of  the  stud-
ies  in  the  literature  comprise  a  limited  number  of  patients
and  are  usually  retrospective.2,3 Due  to  its  low  incidence,  it
is  likely  that  most  cases  of  sinistral  hypertension  are  initially
misdiagnosed  as  a  generalized  portal  hypertension.
Blood  ﬂow  through  the  splenic  vein  may  be  blocked  sec-
ondary  to  either  thrombosis  formation  or  neighboring  mass
effect.1 Following  obstruction,  splenic  blood  typically  drains
through  the  short  gastric  veins  to  the  stomach.  In  the  gastric
wall  veins  of  the  fundus,  blood  ﬂow  and  pressure  increase
and  submucosal  structures  consequently  dilate,  producing
gastric  varices.  Fortunately,  due  to  several  anatomic  varia-
tions,  obstruction  of  the  splenic  vein  may  not  always  resultDOI of original article:
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CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4n  portal  hypertension  or  formation  of  varices.  It  is  believed
hat  similar  pathophysiological  mechanisms  may  occur  in
ases  of  superior  mesenteric  vein  obstruction,  although  in
his  case  the  risk  of  ectopic  varices  involving  the  proximal
mall  bowel  might  be  more  common.
A  recent  study  conﬁrmed  the  past  presumptive  knowl-
dge  that  most  common  pathologies  resulting  in  splenic
ein  thrombosis  or  obstruction  and  leading  to  LSPH  are
hronic  pancreatitis,  pancreatic  pseudocysts  and  pancre-
tic  neoplasms.4 In  particular,  the  presence  of  pseudocyst
n  patients  with  chronic  pancreatitis  might  be  associ-
ted  with  signiﬁcantly  higher  incidence  of  splenic  vein
hrombosis.5 These  account  for  about  18%  of  the  LSPH  cases
nclude  benign  neoplasms,  adenocarcinoma  and  functioning
nd  non-functioning  neuroendocrine  tumors.6,7 Iatrogenic
plenic  vein  injury  after  liver  transplantation,  inﬁltration
y  colonic  tumor,  spontaneous  splenic  vein  thrombosis  and
erirenal  abscess  have  also  been  linked  with  LSPH,  but  these
tiological  factors  are  rare.1
The  diagnosis  of  sinistral  portal  hypertension  should  be
onsidered  in  all  those  with  upper  gastrointestinal  bleed-
ng  associated  with  splenomegaly  and  normal  liver  function
ests.  Most  commonly,  however,  LSPH  is  asymptomatic  and
s  found  incidentally  on  investigation.  In  up  to  73%  of  the
ymptomatic  cases,2 the  ﬁrst  clinical  manifestation  of  LSPH,
s  generally  acute  (often  massive)  or  chronic  upper  gas-
rointestinal  bleeding  from  ruptured  esophageal  or  gastric
arices,  and  rarely  from  colonic  varices.8 Up  to  71%  of
atients  have  splenomegaly,  few  patients  suffer  from  splenic
ain  and  develop  leukopenia  or  thrombocytopenia.2 As  the
 by Elsevier España, S.L.U. This is an open access article under the
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ajority  of  patients  does  not  present  with  cirrhosis,  devel-
pment  of  ascites  is  rare  unless  they  develop  acute  dilutional
ypoalbuminemia  for  any  reason.1
While  diagnosis  is  mainly  clinical  and  often  made  by
xclusion  of  systemic  portal  hypertension,  diagnostic  imag-
ng  plays  an  important  role  in  conﬁrming  the  diagnosis  in
he  majority  of  cases.9 Angiography  of  splenic  vein  remains
he  gold  standard  in  diagnosing  sinistral  portal  hyperten-
ion,  although  it  is  less  used  today  by  the  availability  of
ess  invasive  methods.  Transabdominal  ultrasonography  (US)
ith  Doppler  is  often  the  initial  imaging  modality  utilized,
ut  it  is  more  helpful  in  excluding  presence  of  systemic
ortal  hypertension  and  its  primary  etiologies  such  as  liver
irrhosis.  The  accuracy  of  trans-abdominal  US  is  limited
n  detecting  splenic  or  superior  mesenteric  veins  throm-
osis,  which  are  smaller  and  more  subtle  than  those  of
ortal  veins.10 Recently,  endoscopic  ultrasound  (EUS)  has
een  used  to  assess  the  portal  vasculature.  This  method
ppears  to  be  a  more  accurate  test  than  transabdominal
S  for  evaluating  patency  of  the  splenic  vein.11 EUS  should
e  considered  when  other  diagnostic  methods  have  failed
o  conﬁrm  splenic  vein  thrombosis  as  a  cause  of  bleeding
astric  or  gastroesophageal  varices,  especially  in  patients
ith  previous  history  of  pancreatitis.1 It  should  also  be
onsidered  in  cases  occurring  without  previous  history  of
hronic  pancreatitis,  so  that  pancreatic  carcinoma  can  be
nvestigated  as  a  potential  cause.  In  recent  years  contrast
nhanced  CT  scan  and  magnetic  resonance  angiography  are
aining  popularity  due  to  faster  acquisition  of  images  with
ow  invasiveness.9 However,  the  sensitivity  and  speciﬁcity
or  detection  of  minor  alterations  of  splenic  vasculature  are
till  modest.
Management  of  this  condition  traditionally  involves
emoval  of  the  primary  cause  if  possible,  which  can  be
ombined  with  splenectomy.  Symptomatic  patients  with
ariceal  bleeding  may  be  severe  and  life  threatening.  Cur-
ent  guidelines  recommend  endoscopic  therapy  as  ﬁrst-line
reatment  for  bleeding  gastric  varices.  Endoscopic  thera-
eutic  options  for  gastric  variceal  bleeding  include  band
igation,  cyanoacrylate  (CYA)  injection,  and  thrombin.  The
reatest  evidence  exists  for  CYA  injection,  which  is  rec-
mmended  as  ﬁrst-line  endoscopic  therapies  in  both  the
merican  Association  for  the  Study  of  Liver  Diseases  guide-
ines  and  by  the  Baveno  V  consensus.12,13 CYA  injection
s  also  indicated  as  the  ﬁrst-line  endoscopic  treatment  of
ctopic  small  bowel  varices.14 Main  complications  include
ulmonary  or  portal  vein  embolism.  Recently,  Bhat  et  al
eported  the  six-year  experience  of  EUS-guided  treatment
f  gastric  fundal  varices  with  combined  injection  of  coils
nd  CYA  in  152  patients.15 Treatment  was  technically  suc-
essful  in  the  majority  (99%),  with  re-bleeding  in  only  3%
uring  long-term  follow-up.  The  injection  of  CYA  with  coils
nder  EUS  guidance  appears  to  increase  the  efﬁcacy,  and
ay  reduce  the  risk  of  CYA  embolization.
A  patient  with  active  bleeding  unresponsive  to  conser-
ative  management  should  be  submitted  to  an  emergent
plenectomy,  which  decreases  the  venous  outﬂow  through
he  collateral  circulation  and  decompresses  the  associated
arices.1 Embolization  of  the  splenic  artery  by  selective
atheterization  has  been  tried  with  varying  success  and
hould  be  an  option  in  patients  who  are  not  medically  ﬁt  for
 splenectomy  procedure,  depending  of  local  expertise.16
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anagement  of  asymptomatic  patients  is  more  controversial
han  the  symptomatic  ones:  splenectomy  has  been  sug-
ested  as  a  prophylactic  measure  by  some  while  others
ave  not  shown  any  signiﬁcant  beneﬁt  of  this  procedure
n  survival.  However,  more  evidence  suggests  that  watchful
aiting  as  acceptable  course  of  management  in  asymp-
omatic  individuals.9
Excluding  deaths  from  gastrointestinal  bleeding,  the
rognosis  of  LSPH  mainly  depends  on  the  underlying  disease,
ith  those  with  pancreatic  malignancies  having  the  worst
utcomes.  As  such,  the  evidence  LSPH,  although  benign  in
ost  cases,  can  sometimes  be  the  ﬁrst  signal  of  a  sinister
ntity,  like  the  pancreatic  cancer.
In  this  issue  of  GE  Portuguese  Journal  of  Gastroenterol-
gy,  Fernandes  et  al17 report  the  clinical  presentation,
tiologies  and  outcome  in  a  cohort  of  22  patients  with  LSH.
his  retrospective  analysis  highlights  some  particular  issues
egarding  this  difﬁcult  to  diagnose  and  manage  entity.  Sim-
larly  to  reported  series,  most  patients  (n  =  14)  experience
o  symptoms  or  presented  non-speciﬁc  abdominal  pain,  and
SH  was  found  incidentally  on  investigation.  This  raises
he  question  about  the  value  of  screening  asymptomatic
atients  for  the  presence  of  LSPH.  Bernardes  et  al.  search
or  splenoportal  venous  obstruction  in  a medical-surgical
rospective  series  of  266  patients  with  chronic  pancreatitis
ho  were  followed  up  a  mean  time  of  8.2  years18 Spleno-
ortal  venous  obstruction  was  found  in  35  patients  (13.2%)
ut  was  symptomatic  in  only  two.  Development  of  varices  in
SPH  occurs  only  when  formation  of  adequate  low-pressure
ollateral  do  not  develop,  so  diagnostic  test  should  evalu-
te  not  only  splenic  vein  obstruction  but  also  the  presence
f  varices.  In  this  context,  EUS  may  be  the  ideal  diagnostic
odality  since  it  can  be  used  to  assess  portal  vasculature,
atency  of  splenic  vein  and  to  diagnose  gastric  varices.
n  this  cohort  of  patients  EUS  was  used  in  nine  patients
ith  conﬁrmation  of  gastrointestinal  varices  in  all  of  them.
oreover,  the  authors  ﬁnd  that  the  principal  etiology  of
SPH  was  pancreatic  pathology  (chronic  pancreatitis,  acute
ancreatitis  and  pancreatic  tumours),  situations  in  which
US  has  demonstrated  superior  accuracy  to  transabdominal
S  or  abdominal  CT.  Another  controversial  issue  raised  by
his  study  is  the  management  of  LSPH,  namely  the  treat-
ent  of  varices  and  the  need  to  initiate  anticoagulation
herapy.  In  this  regard,  we  agree  with  the  authors  that  anti-
oagulation  therapy  should  be  instituted  after  treatment
f  varices,  since  it’s  difﬁcult  to  determinate  the  poten-
ial  risk  of  bleeding  from  gastric  varices.  CYA  obliteration
s  the  recommend  approach  to  control  upper  gastrointesti-
al  bleeding,  however  treatment  of  asymptomatic  patients
ith  gastric  varices  is  not  consensual  since  this  treatment  is
ssociated  with  risk  of  embolic  events.
This  pertinent  study  brings  to  the  forefront  a  condition
ot  as  uncommon  as  previously  thought,  but  whose  approach
emains  based  on  small  cases  series  and  clinical  cases  and
hose  consequences  can  be  catastrophic.eferences
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